Pursuant to Regulation 30 of the Listing Obligations and Disclosure Requirements Regulations, 2015, we wish to inform you that officials of the Food and Drug Administration (FDA), Nashik, ....
ELITECON · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
On January 8, 2026, officials from the Food and Drug Administration (FDA), Nashik conducted an inspection at Elitecon International's manufacturing facility in Dindori, Nashik, Maharashtra. The inspection was carried out under the Food Safety and Standards Act, 2006, in connection with a Government of Maharashtra notification dated July 20, 2025, related to tobacco products. During the inspection, the authorities seized certain inventories of tobacco products along with one packing and sealing machine. The matter is currently under review by the appropriate authorities. The company has stated that other business operations continue normally and there is no material impact on overall operations or its going concern status, though the financial impact cannot be quantified at this stage.
This is a regulatory enforcement action that could potentially lead to penalties or restrictions on tobacco product manufacturing. While the company downplays the impact, the seizure of inventory and machinery, combined with the uncertain financial outcome, may create short-term uncertainty for shareholders.